Skip to content
Server Security Center
KEVhigh7.5

CVE-2023-38950: ZKTeco BioTime Path Traversal

ZKTeco BioTime · listed in the CISA catalog of actively exploited vulnerabilities since 2025-05-19.

CVSS v3.1 (CISA ADP)
7.5
high
EPSS (exploit probability, 30 days)
92%
higher than 99.8% of all CVEs
Added to CISA KEV
2025-05-19
US federal due date 2025-06-09
Automatable (CISA SSVC)
yes
technical impact: partial

What is CVE-2023-38950?

A path traversal vulnerability in the iclock API of ZKTeco BioTime v8.5.5 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload. This vulnerability was fixed in version 9.0.120240617.19506 of ZKBioTime.

CISA required action: Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.

CISA notes

How to fix it

  • The CVE record names no fixed version – check the vendor advisory and CISA's required action for updates and mitigations.
  • Vendor advisory: zkteco.com/en/Security_Bulletinsibs
  • CISA's deadline for US federal agencies: 2025-06-09 (passed) – a useful benchmark for everyone else, too.

CISA's assessment (SSVC)

Exploitation
Exploited in the wild
Automatable
Yes – attackers can automate it at scale
Technical impact
Partial – limited control or information

Weakness: CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

References

Data: CISA Known Exploited Vulnerabilities (public domain) · CVE Program records incl. CISA ADP enrichment · OSV.dev (CC BY 4.0) incl. Ubuntu and Debian security data · FIRST EPSS · endoflife.date. Updated automatically – facts last changed 2026-11-21. Always confirm with the vendor's or distribution's advisory before patching.